Kanishka Sircar

8.3k total citations
91 papers, 4.2k citations indexed

About

Kanishka Sircar is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Kanishka Sircar has authored 91 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 40 papers in Molecular Biology and 38 papers in Surgery. Recurrent topics in Kanishka Sircar's work include Renal cell carcinoma treatment (45 papers), Bladder and Urothelial Cancer Treatments (24 papers) and Renal and related cancers (20 papers). Kanishka Sircar is often cited by papers focused on Renal cell carcinoma treatment (45 papers), Bladder and Urothelial Cancer Treatments (24 papers) and Renal and related cancers (20 papers). Kanishka Sircar collaborates with scholars based in United States, Canada and Spain. Kanishka Sircar's co-authors include Robert H. Riddell, Bryan R. Hewlett, Jan D. Huizinga, Armen Aprikian, Christopher G. Wood, Pheroze Tamboli, Nizar M. Tannir, José A. Karam, I. Berezin and Eric Jonasch and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Kanishka Sircar

90 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kanishka Sircar United States 34 2.5k 1.6k 1.3k 1.0k 892 91 4.2k
Shigeki Sekine Japan 47 1.8k 0.8× 2.0k 1.3× 2.1k 1.6× 894 0.9× 2.3k 2.6× 188 6.2k
Yoshiki Mikami Japan 41 1.1k 0.4× 737 0.5× 1.5k 1.2× 656 0.6× 921 1.0× 231 5.3k
Mercè Jordà United States 33 1.3k 0.5× 855 0.5× 977 0.8× 461 0.4× 1.0k 1.1× 157 3.2k
Jaclyn F. Hechtman United States 33 1.9k 0.8× 1.1k 0.7× 1.2k 0.9× 1.2k 1.2× 2.6k 2.9× 116 4.6k
Hans‐Ulrich Schildhaus Germany 32 2.0k 0.8× 995 0.6× 927 0.7× 686 0.7× 1.7k 1.9× 190 4.2k
Alexa B. Schrock United States 41 3.1k 1.3× 1.7k 1.1× 1.0k 0.8× 1.8k 1.7× 3.7k 4.1× 259 6.0k
Reiji Haba Japan 31 1.2k 0.5× 692 0.4× 880 0.7× 527 0.5× 1.1k 1.3× 216 3.5k
Kyoung‐Mee Kim South Korea 49 4.0k 1.6× 2.0k 1.3× 2.4k 1.9× 1.3k 1.3× 3.4k 3.8× 313 8.3k
Roland Penzel Germany 40 1.5k 0.6× 1.7k 1.1× 602 0.5× 1.3k 1.2× 1.8k 2.0× 134 4.4k
Takahiro Hasebe Japan 40 944 0.4× 1.4k 0.9× 1.1k 0.8× 1.4k 1.3× 2.5k 2.7× 173 4.8k

Countries citing papers authored by Kanishka Sircar

Since Specialization
Citations

This map shows the geographic impact of Kanishka Sircar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanishka Sircar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanishka Sircar more than expected).

Fields of papers citing papers by Kanishka Sircar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanishka Sircar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanishka Sircar. The network helps show where Kanishka Sircar may publish in the future.

Co-authorship network of co-authors of Kanishka Sircar

This figure shows the co-authorship network connecting the top 25 collaborators of Kanishka Sircar. A scholar is included among the top collaborators of Kanishka Sircar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanishka Sircar. Kanishka Sircar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brennan, Patrick M., et al.. (2024). Best practices and recommendations for grossing and reporting of post-immunotherapy nephrectomy specimens: a single-institution experience of 70 cases. Diagnostic histopathology. 30(5). 275–281. 2 indexed citations
2.
Hahn, Andrew W., Devaki Shilpa Surasi, Tharakeswara Bathala, et al.. (2023). Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. The Oncologist. 29(5). 392–399. 4 indexed citations
3.
Alhalabi, Omar, Sylvie Négrier, Yann Vano, et al.. (2023). Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas. The Oncologist. 28(5). 433–439. 13 indexed citations
4.
Hahn, Andrew W., et al.. (2022). The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma. Cancer Treatment and Research Communications. 33. 100640–100640. 15 indexed citations
5.
Guo, Tao, Ji Won Hwang, Pheroze Tamboli, et al.. (2021). A generative adversarial approach to facilitate archival-quality histopathologic diagnoses from frozen tissue sections. Laboratory Investigation. 102(5). 554–559. 13 indexed citations
6.
Surasi, Devaki Shilpa, Priya Rao, Kanishka Sircar, et al.. (2021). Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma. Cancers. 13(9). 2170–2170. 21 indexed citations
7.
8.
Pieretti, Alberto, Mary E. Westerman, Niki M. Zacharias, et al.. (2021). Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 39(11). 790.e17–790.e23. 5 indexed citations
9.
Malouf, Gabriel G., Siraj M. Ali, Kai Wang, et al.. (2016). Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations. European Urology. 70(2). 348–357. 90 indexed citations
10.
Phan, Liem, Enrique Fuentes‐Mattei, Weixin Wu, et al.. (2015). Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Research. 75(19). 4131–4142. 34 indexed citations
11.
Kalra, Sarathi, Bradley J. Atkinson, Surena F. Matin, et al.. (2014). Outcomes of patients with metastatic renal cell carcinoma and bone metastases in the targeted-therapy era.. Journal of Clinical Oncology. 32(4_suppl). 528–528. 1 indexed citations
12.
Jonasch, Eric, et al.. (2013). Impact of chromosomal copy number variation on outcome in metastatic clear cell renal cell carcinoma patients treated with antiangiogenic agents.. Journal of Clinical Oncology. 31(6_suppl). 393–393. 2 indexed citations
13.
Abourbih, Samuel, Kanishka Sircar, Simon Tanguay, et al.. (2013). Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study. World Journal of Surgical Oncology. 11(1). 298–298. 17 indexed citations
14.
Sircar, Kanishka, Heng Huang, Limei Hu, et al.. (2012). Mitosis Phase Enrichment with Identification of Mitotic Centromere-Associated Kinesin As a Therapeutic Target in Castration-Resistant Prostate Cancer. PLoS ONE. 7(2). e31259–e31259. 14 indexed citations
15.
Chuang, Hubert H., Ferhat Denız, Kanishka Sircar, et al.. (2012). [18F]Fluorodeoxyglucose Positron Emission Tomography–Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case. Journal of Clinical Oncology. 30(26). e246–e249. 4 indexed citations
16.
Tzelepi, Vassiliki, Jiexin Zhang, Guanglin Wu, et al.. (2011). Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features. Clinical Cancer Research. 18(3). 666–677. 105 indexed citations
17.
Perrier, Nancy D., Elizabeth G. Grubbs, Kanishka Sircar, et al.. (2011). CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clinical Radiology. 67(1). 38–46. 46 indexed citations
18.
Gorlov, Ivan P., Kanishka Sircar, Hongya Zhao, et al.. (2010). Prioritizing genes associated with prostate cancer development. BMC Cancer. 10(1). 599–599. 30 indexed citations
19.
Youssif, Tamer Abou, Abdulaziz Al-Khaldi, Kanishka Sircar, et al.. (2009). Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome. British Journal of Urology. 104(10). 1467–1470. 69 indexed citations
20.
Sircar, Kanishka, et al.. (2000). Gastrointestinal Stromal Tumors May Originate from a Subset of CD34-Positive Interstitial Cells of Cajal. American Journal Of Pathology. 156(4). 1157–1163. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeki Sekine Breakdown of academic impact, for papers by Yoshiki Mikami Breakdown of academic impact, for papers by Mercè Jordà Breakdown of academic impact, for papers by Jaclyn F. Hechtman Breakdown of academic impact, for papers by Hans‐Ulrich Schildhaus Breakdown of academic impact, for papers by Alexa B. Schrock Breakdown of academic impact, for papers by Reiji Haba Breakdown of academic impact, for papers by Kyoung‐Mee Kim Breakdown of academic impact, for papers by Roland Penzel Breakdown of academic impact, for papers by Takahiro Hasebe
Rankless by CCL
2026